Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: Models for antiviral evaluations

Antiviral Research

Volumn 47, Issue 3, 2000, Pages 159-169

  Bernstein, David I ^a   Ireland, Jim ^a   Bourne, Nigel ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Acyclovir resistant; Animal models; Genital herpes; Pathogenesis

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FOSCARNET; THYMIDINE KINASE;

ANIMAL MODEL; ARTICLE; DISEASE SEVERITY; FEMALE; GENITAL HERPES; GENITAL TRACT INFECTION; GUINEA PIG; HERPES; HERPES SIMPLEX VIRUS 2; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS INFECTION; VIRUS ISOLATION;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, MICROBIAL; FEMALE; FOSCARNET; GUINEA PIGS; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MICE; RABBITS; REVERSE TRANSCRIPTASE INHIBITORS; VERO CELLS; VIRUS ACTIVATION;

EID: 0033814075     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(00)00104-2     Document Type: Article

References (44)

1. Bernstein D.I., Stanberry L.R., Harrison C.J., Kappes J.C., Myers M.G. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea pigs: effects of acyclovir. J. Gen. Virol. 67:1986;1601-1612.
2. Christophers J., Sutton R.N. Characterization of acyclovir-resistant and -sensitive clinical herpes simplex virus isolates from an immunocompromised patient. J. Antimicrob. 20:1987;389-398.
3. Coen D.M., Kosz-Vnenchak M., Jacobson J.C., Leib D.A., Bogard C.L., Schaffer P.A., Tyler K.L., Knipe D.M. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. U.S.A. 86:1989;4736-4740.
4. Coen D.M. Acyclovir-resistant, pathogenic herpesviruses. Trends Microbiol. 2:1994;481-485.
5. Collins P., Ellis M.D. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J. Med. Virol. 1:1993;58-66.
6. Da Costa X.J., Bourne N., Stanberry L.R., Knipe D.M. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease. Virology. 26:1997;1-12.
7. Darby G., Church M.J., Larder B.A. Cooperative effects between two acyclovir resistance loci in herpes simplex virus. J. Virol. 50:1984;838-846.
8. Efstathiou S., Kemp S., Darby G., Minson A.C. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J. Gen. Virol. 70:1989;869-879.
9. Erlich K.S., Mills J., Chatis P., Mertz G.J., Busch D.F., Folansbee S.E., Grant R.M., Crumpacker C.S. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. New Engl. J. Med. 320:1989;293-296.
10. Erlich K.S., Jacobson M.A., Koehler J.E., Follansbee S.E., Drennan D.P., Gooze L., Safrin S., Mills J. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with acquired immunodeficiency syndrome (AIDS). An uncontrolled trial. Ann. Intern. Med. 110:1989;710-713.
11. Fleming D.T., McQuillan G.M., Johnson R.E., Nahmias A.J., Aral S.O., Lee F.K., St. Louis M.E. Herpes simplex virus type 2 in the United States, 1976 to 1994. New Engl. J. Med. 337:1997;1105-1111.
12. Fowler S.L., Harrison C.J., Myers M.G., Stanberry L.R. Outcome of herpes simplex virus type 2 infection in guinea pigs. J. Med. Virol. 36:1992;303-308.
13. Gordon Y., Gilden D.H., Shtram T., Asher Y., Tabor E., Wellish M., Devlin M., Snipper P., Hadar J., Becker Y. A low thymidine kindase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice. Arch. Virol. 76:1983;39-49.
14. Harrison C.J., Miller R.L., Bernstein D.I. Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs. Antimicrob. Chemother. 38:1994;2059-2064.
15. Hill E.L., Hunter G.A., Ellis M.N. In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 35:1991;2322-2328.
16. Horsburgh B.C., Chen S.-H., Hu A., Mulamba G.B., Burns W.H., Coen D.M. Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: can strain differences compensate for loss of thymidine kinase in pathogenesis? J. Infect. Dis. 178:1998;618-625.
17. Hwang C.B., Horsburgh B., Pelosi E., Roberts S., Digard P., Coen D.M. A net +1 frameshift permits synthesis of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob. Agents Chemother. 28:1994;181-187.
18. Jacobson J.G., Ruffner K.L., Kosz-Vnenchak M., Hwang C.B., Wobbe K.K., Knipe D.M., Coen D.M. Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia. J. Viol. 67:1993;6903-6908.
19. Kimberlin D.W., Coen D.M., Biron K.K., Cohen J.L., Lamb R.A., McKinlay M., Emini E.A., Whitley R.J. Molecular mechanisms of antiviral resistance. Antiviral Res. 26:1995;369-401.
20. Kost R.G., Hill E.L., Tigges M., Straus S.E. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. New Engl. J. Med. 329:1993;1777-1782.
21. Landry M.L., Myerson D., Bull C. Recurrent genital infection in the guinea pig: differences between herpes simplex types 1 and 2. Intervirology. 34:1992;169-179.
22. Ljungman P., Ellis M.N., Hackman R.C., Shepp D.H., Meyers J.D. Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation. J. Infect. Dis. 162:1990;244-248.
23. LoPresti A.E., Levin J.F., Munk G.B., Tai C.Y., Mendel D.B. Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir. Clin. Infect. Dis. 26:1998;512-513.
24. Marks G.L., Nolan P.E., Erlich K.S., Ellis M.N. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS. Rev. Infect. Dis. 11:1989;474-476.
25. Martin J.L., Ellis M.N., Keller P.M., Biron K.K., Lehrman S.N., Barry D.W., Furman P.A. Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob. Agents Chemother. 28:1985;181-187.
26. Meignier B., Longnecker R., Mavromara-Nazos P., Sears A.E., Roizman B. Virulence and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1. Virology. 162:1988;251-254.
27. Milligan G.N., Bernstein D.I. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virology. 206:1995;234-241.
28. Milligan G.N., Bernstein D.I. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology. 229:1997;259-268.
29. Mouly F., Baccard M., Scieux C., Schnell L., Locq-Ebner S., Morinet F., Morel P. Chronic recurrent acyclovir-resistant genital herpes in an immunocompetent patient. Dermatology. 190:1995;177.
30. Nyquist A.C., Rotbart H.A., Cotton M., Robinson C., Weinberg A., Hayward A.R., Berens R.L., Levin M.J. Acyclovir-resistant neonatal herpes simplex virus infection of the larynx. J. Pediatr. 124:1994;967-971.
31. Sacks S.L., Wanklin R.J., Reecho D.E., Hicks K.A., Tyler K.L., Coen D.M. Progressive esophagi's from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity? Ann. Intern. Med. 111:1989;893-899.
32. Safrin S., Crumpacker C., Chatis P., Davis R., Hafner R., Rush J., Kessler H.A., Landry B., Mills J. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. New Engl. J. Med. 325:1991;551-555.
33. Safrin S., Kimberly S., Poltroon B., Smith T., Weissbach N., De Veranez D., Phan L., Cohn D. Foscarnet-resistant herpes simplex virus infection in patients with AIDS. J. Infect. Dis. 169:1994;193-196.
34. Sasadeusz J.J., Sacks S.L. Spontaneous reactivation of thymidine kinase-deficient, acyclovir-resistant type 2 herpes simplex virus: masked heterogeneity or reversion? J. Infect. Dis. 174:1996;476-482.
35. Sasadeusz J.J., Tufaro F., Safrun S., Schubert K., Hubinette M.M., Cheung P.K., Sacks S.L. Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J. Virol. 71:1997;3872-3878.
36. Sears A.E., Meignier B., Roizman B. Establishment of latency in mice by herpes simplex virus 1 recobminants that carry insertions affection regulation of the thymidine kinase gene. J. Virol. 55:1985;410-416.
37. Snoeck R., Andrei G., Gerard M., Silverman A., Hedderman A., Balzarin J., Sadzot-Delvaux C., Tricot G., Clumeck N., De Clercq E. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytostine (HPMPC). Clin. Infect. Dis. 18:1994;570-578.
38. Stanberry L.R., Kern E.R., Richards J.J., Abbott T.M., Overall J.C. Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J. Infect. Dis. 146:1982;397-404.
39. Stanberry L.R., Kern E.R., Richards J.J., Overall J.C. Recurrent genital herpes simplex virus infection in guinea pigs. Intervirology. 24:1985;226-231.
40. Stanberry L.R., Kit S., Myers M.G. Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs. J. Virol. 55:1985;322-328.
41. Stanberry L.R., Bernstein D.I., Kit S., Myers M.G. Genital reinfection after recovery from initial genital infection with herpes simplex virus type 2 in guinea pigs. J. Infect. Dis. 153:1986;1055-1061.
42. Stroop W.G., Banks M.C., Qavi H., Chodosh J., Brown S.M. A Thymidine kinase deficient HSV-2 strain causes acute keratitis and establishes trigeminal ganglionic latency, but poorly reactives in vivo. J. Med. Virol. 43:1994;297-309.
43. Swetter S.M., Hill E.L., Kern E.R., Koelle D.M., Posavad C.M., Lawrence W., Safrin S. Chronic vulvular ulceration in an immunocompetent woman due to acyclovir-resistant thymidine kinase-deficient herpes simplex virus. J. Infect. Dis. 177:1998;543-550.
44. Tenser R.B., Edris W.A. Trigeminal ganglion infection by thymidine kinase-negative mutants of herpessimplex virus after in vivo complementation. J. Virol. 61:1987;2171-2174.